MAYNE PHARMA GROUP LIMITED — Major Shareholding Notification 2012

Aug 28, 2012

603 page1/2 13 March 2000

Form 603

Corporations Law Section 671B

Notice of initial substantial holder

To Company Name/Scheme MAYNE PHARMA GROUP LIMITED

ACN/ARSN

1. Details of substantial holder(1)

Name Australian Leaders Fund Limited

ACN /ARSN (if applicable) 106 845 970

The holder became a substantial holder on 24/08/2012

2. Details of voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows:

Class of securities (4)	Number of securities	Persons' votes (5)	Voting power (6)
FPO	7,644,395	7,644,395	5.02%*

*Based on issued capital of 152,153,044 shares

3. Details of relevant interests

The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows:

Holder of relevant interest	Nature of relevant interest (7)	Class and number of securities
See Schedule 1

4. Details of present registered holders

The persons registered as holders of the securities referred to in paragraph 3 above are as follows:

Holder of relevant interest	Registered holder of securities	Person entitled to be registered as holder (8)	Class and number of securities
See Schedule 1

5. Consideration

The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows:

Holder of relevant interest	Date of acquisition	Consideration (9)	Consideration (9)	Class and number of securities
		Cash	Non-cash
Braitling Investments Pty Ltd	Various dates between 24/03/12 and 24/08/12	($829,753)		2,265,246 FPO

SYD4_136354_1 (W97)

603 page 2/2 13 March 2000

6. Associates

The reasons the persons named in paragraph 3 above are associates of the substantial holder are as follows:

Name and ACN/ARSN (if applicable)	Nature of association
N/A

7. Addresses

The addresses of persons named in this form are as follows:

Name	Address
Braitling Investments Pty Ltd	Level 11, 139 Macquarie Street, Sydney NSW 2000
Australian Leaders Fund Ltd	Level 7, 20 Hunter Street, Sydney NSW 2000

Signature

print name Justin Braitling capacity Director
ign here date 28 / 08 / 12
DIRECTIONS
number of substantial holders with similar or related relevant interests (eg. a corporation and its related
, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the
rests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically
p if the membership of each group, with the names and addresses of members is clearly set out in paragraph 7 of
nition of 'associate' in section 9 of the_Corporations Law_.
nition of 'relevant interest' in sections 608 and 671B(7) of the_Corporations Law_.
hares of a company constitute one class unless divided into separate classes.
mber of votes attached to all the voting shares in the company or voting interests in the scheme (if any) that the
associate has a relevant interest in.
s votes divided by the total votes in the body corporate or scheme multiplied by 100.
ils of:
evant agreement or other circumstances by which the relevant interest was acquired. If subsection 671B(4)
s, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving
d accurate details of any contract, scheme or arrangement, must accompany this form, together with a written
ent certifying this contract, scheme or arrangement; and
alification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting
s or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to
the qualification applies).
nition of 'relevant agreement' in section 9 of the_Corporations Law_.
ntial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option)
wn'.
e consideration must include any and all benefits, money and other, that any person from whom a relevant interest
d has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit
l on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the
older or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the
rest was acquired.

sign here

• (1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 7 of the form.

• (2) See the definition of 'associate' in section 9 of the Corporations Law .

• (3) See the definition of 'relevant interest' in sections 608 and 671B(7) of the Corporations Law .

• (4) The voting shares of a company constitute one class unless divided into separate classes.

• (5) The total number of votes attached to all the voting shares in the company or voting interests in the scheme (if any) that the person or an associate has a relevant interest in.

• (6) The person's votes divided by the total votes in the body corporate or scheme multiplied by 100.

• (7) Include details of:

• (a) any relevant agreement or other circumstances by which the relevant interest was acquired. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and

• (b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).

• See the definition of 'relevant agreement' in section 9 of the Corporations Law .

• (8) If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write 'unknown'.

• (9) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

SYD4_136354_1 (W97)

Schedule 1 - Becoming a substantial holder in Mayne Pharma Group Limited - Braitling Investments Pty Ltd/Australian Leaders Fund Limited

Details of relevant interests

Holder of relevant interest	Nature of relevant interest	Nature of relevant interest	Class and number of securities	Class and number of securities	Class and number of securities
Braitling Investments Pty Ltd	Power to (or to control) exercise vote and/or dispose of the securities as discretionary investment managers or advisers of superannuation funds, pooled superannuation trusts, managed investment schemes and investment management agreements.		7,644,395 Fully paid ordinary shares
Holder of relevant Interest	Registered Holder of securities	Person entitled to be registed as holder	Nature of relevant interest	Class and no. of securities	Persons votes
Braitling Investments Pty Ltd	UBS Nominees Ltd	UBS Nominees Ltd	Investment Manager	7,644,395	7,644,395